(Q49110758)

18 February 2018

title

Guanfacine and Other Centrally Acting Drugs in Antihypertensive Therapy; Pharmacological and Clinical Aspects (English)

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

15 September 2023

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

15 September 2023

author name string

K. Saameli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6280899

15 September 2023

P. Jerie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6280899

15 September 2023

G. Scholtysik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6280899

15 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6280899

15 September 2023

publication date

1 January 1982

1 reference

18 February 2018

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/10641968209061586

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

Clinical and Experimental Hypertension

15 September 2023

published in

1 reference

18 February 2018

volume

4

1 reference

18 February 2018

issue

1-2

1 reference

18 February 2018

page(s)

209-219

1 reference

18 February 2018

Evidence for a central noradrenaline receptor stimulation by clonidine

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Effect of Chronic Clonidine Treatment and its Abrupt Cessation on Mean Blood Pressure of Rats with a Normal or An Elevated Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Pre- and postsynaptic effects of α-agonists inthe anococcygeus muscle of the pithed rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Clonidine withdrawal. Mechanism and frequency of rebound hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Effects of clonidine withdrawal: possible mechanisms and suggestions for management.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Clinical experience with guanfacine in long-term treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Pharmacokinetics and metabolism of guanfacine in man: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Effects of clonidine and BS 100–141 on the EEG sleep pattern in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Haemodynamic effects of guanfacine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

An ambulatory trial of guanfacine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Guanfacine: effects of long-term treatment and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

[Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968209061586

Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine

21 January 2018

4

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

Effects of abrupt cessation of treatment with clonidine and guanfacine on blood pressure and heart rate in spontaneously hypertensive rats

15 September 2023

16

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

Clinical and Experimental Pharmacology and Physiology

15 September 2023

26

207

Saameli K.

1975

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats

15 September 2023

27

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

Guanfacine kinetics in patients with hypertension

15 September 2023

33

1 reference

https://api.crossref.org/works/10.3109/10641968209061586

15 September 2023

Identifiers

1 reference

18 February 2018

1 reference

18 February 2018